Status:
COMPLETED
An International Cross-sectional Survey to Evaluate the Burden of Fibrodysplasia Ossificans Progressiva (FOP) on Patients and Their Families.
Lead Sponsor:
Ipsen
Conditions:
Fibrodysplasia Ossificans Progressiva
Eligibility:
All Genders
Brief Summary
The FOP burden of illness (BoI) survey aims to assess the impact of the burden of FOP on patients and their families. The study is being conducted online and available for residents in Argentina, Braz...
Eligibility Criteria
Inclusion
- Individuals meeting one of the two categories below (A or B) are eligible to participate: A. Any individual with FOP, of any age; B. Any individual who is a family member of a person with FOP (i.e. either a parent / legal guardian or a sibling) and who is aged 18 years and older
- All adult participants and parents / legal guardians of minors should provide informed consent before starting filling out the survey
Exclusion
- 1\. Any individuals who are unable to complete the online survey independently or to get assistance to physically enter the answers
Key Trial Info
Start Date :
January 18 2021
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
April 30 2021
Estimated Enrollment :
411 Patients enrolled
Trial Details
Trial ID
NCT04665323
Start Date
January 18 2021
End Date
April 30 2021
Last Update
May 21 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ipsen Central Contact
Cambridge, Massachusetts, United States, 02142